Dr. Christopher Hodnette, MD

NPI: 1992140065
Total Payments
$5,252
2024 Payments
$439.85
Companies
22
Transactions
218
Medicare Patients
1,368
Medicare Billing
$158,130

Payment Breakdown by Category

Food & Beverage$5,000 (95.2%)
Education$182.06 (3.5%)
Research$69.78 (1.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $5,000 214 95.2%
Education $182.06 3 3.5%
Unspecified $69.78 1 1.3%

Payments by Type

General
$5,182
217 transactions
Research
$69.78
1 transactions

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $2,948 142 $0 (2024)
Janssen Biotech, Inc. $415.46 17 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $392.55 18 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $162.76 6 $0 (2020)
GENZYME CORPORATION $144.22 2 $0 (2023)
Aries Pharmaceuticals, Inc. $123.50 1 $0 (2018)
Janssen Scientific Affairs, LLC $123.26 1 $0 (2018)
Covidien LP $123.14 1 $0 (2020)
Mallinckrodt Hospital Products Inc. $121.34 1 $0 (2023)
Ironwood Pharmaceuticals, Inc $120.68 8 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $439.85 30 ABBVIE INC. ($314.64)
2023 $779.43 46 ABBVIE INC. ($443.53)
2022 $503.07 22 ABBVIE INC. ($323.16)
2021 $357.47 12 AbbVie Inc. ($236.65)
2020 $386.86 18 Covidien LP ($123.14)
2019 $822.72 24 AbbVie, Inc. ($331.92)
2018 $1,058 29 AbbVie, Inc. ($376.35)
2017 $904.27 37 AbbVie, Inc. ($807.46)

All Payment Transactions

218 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
12/23/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $13.99 General
Category: Gastroenterology
12/10/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $16.76 General
Category: IMMUNOLOGY
11/19/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $26.48 General
Category: GASTROENTEROLOGY
10/22/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $18.04 General
Category: IMMUNOLOGY
10/22/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $4.43 General
Category: IMMUNOLOGY
10/09/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $6.76 General
Category: IMMUNOLOGY
09/17/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $15.11 General
Category: IMMUNOLOGY
09/16/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $13.17 General
Category: GASTROENTEROLOGY
09/10/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $27.51 General
Category: GASTROENTEROLOGY
08/12/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $13.73 General
Category: IMMUNOLOGY
07/29/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $21.04 General
Category: IMMUNOLOGY
05/14/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $18.68 General
Category: IMMUNOLOGY
05/13/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $1.22 General
Category: IMMUNOLOGY
05/09/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $11.17 General
Category: ENDOCRINOLOGY
04/22/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $15.88 General
Category: IMMUNOLOGY
04/13/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $16.24 General
Category: GASTROENTEROLOGY
04/02/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $4.79 General
Category: IMMUNOLOGY
03/26/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $16.77 General
Category: IMMUNOLOGY
03/25/2024 ABBVIE INC. HUMIRA (Biological), RINVOQ Food and Beverage In-kind items and services $18.89 General
Category: IMMUNOLOGY
03/08/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $16.16 General
Category: IMMUNOLOGY
03/05/2024 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $20.31 General
Category: Immunology
02/20/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $17.39 General
Category: GASTROENTEROLOGY
02/20/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $14.61 General
Category: IMMUNOLOGY
02/08/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $2.00 General
Category: IMMUNOLOGY
01/12/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $18.13 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 262 270 $179,584 $28,774
2022 10 366 387 $235,432 $44,149
2021 10 397 429 $230,059 $44,880
2020 12 343 398 $241,366 $40,327
Total Patients
1,368
Total Services
1,484
Medicare Billing
$158,130
Procedure Codes
40

All Medicare Procedures & Services

40 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 59 60 $77,460 $11,635 15.0%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 41 42 $18,816 $5,225 27.8%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 59 59 $43,365 $4,540 10.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 45 46 $11,050 $3,280 29.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 22 23 $5,405 $1,454 26.9%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 20 24 $3,840 $1,376 35.8%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 16 16 $19,648 $1,265 6.4%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 74 74 $83,472 $14,713 17.6%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 39 43 $19,264 $6,489 33.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 75 81 $19,035 $5,713 30.0%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 67 69 $50,715 $5,106 10.1%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 22 22 $7,942 $2,455 30.9%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2022 13 13 $10,790 $2,444 22.6%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 33 42 $7,011 $2,320 33.1%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 11 11 $9,130 $2,067 22.6%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 21 21 $21,000 $1,903 9.1%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 11 11 $7,073 $939.85 13.3%
45385 Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare Facility 2021 60 61 $68,808 $11,989 17.4%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 103 118 $27,730 $9,678 34.9%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 37 37 $19,852 $5,917 29.8%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 64 68 $49,980 $5,786 11.6%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 23 23 $8,303 $2,742 33.0%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 33 38 $8,990 $2,182 24.3%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 21 27 $13,360 $2,111 15.8%
45380 Biopsy of the large bowel using an endoscope (colonoscopy) Facility 2021 17 18 $18,000 $1,603 8.9%

About Dr. Christopher Hodnette, MD

Dr. Christopher Hodnette, MD is a Emergency Medicine healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2013. The National Provider Identifier (NPI) number assigned to this provider is 1992140065.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Hodnette, MD has received a total of $5,252 in payments from pharmaceutical and medical device companies, with $439.85 received in 2024. These payments were reported across 218 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,000).

As a Medicare-enrolled provider, Hodnette has provided services to 1,368 Medicare beneficiaries, totaling 1,484 services with total Medicare billing of $158,130. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.

Practice Information

  • Specialty Emergency Medicine
  • Other Specialties Internal Medicine
  • Location Baton Rouge, LA
  • Active Since 05/02/2013
  • Last Updated 03/23/2018
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • NPI Number 1992140065

Products in Payments

  • Humira (Biological) $969.87
  • RINVOQ (Biological) $668.78
  • STELARA (Biological) $381.78
  • HUMIRA (Biological) $278.31
  • Entyvio (Biological) $219.79
  • SKYRIZI (Biological) $201.66
  • Mavyret (Drug) $179.81
  • REMICADE (Biological) $156.94
  • DUPIXENT (Biological) $144.22
  • CREON (Drug) $141.34
  • ELEVIEW (Device) $123.50
  • EndoFlip (Device) $123.14
  • TERLIVAZ (Drug) $121.34
  • Linzess (Drug) $120.68
  • XIFAXAN (Drug) $112.21
  • XELJANZ (Drug) $99.94
  • LINX Reflux Management System (Device) $92.72
  • LINZESS (Drug) $91.28
  • TRULANCE (Drug) $90.71
  • Viekira (Drug) $88.11

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in Baton Rouge